ReviewCancers2026

Neoadjuvant Advantage, Adjuvant Challenge: Clinical Evidence and Hypothetical Biological Mechanisms Behind Divergent Tolerability.

Patrícia Dias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.